Ureas for the treatment and prevention of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8937088
APP PUB NO 20130296380A1
SERIAL NO

13978693

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A compound of Formula (I), salts thereof, prodrugs thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions to treat diseases mediated by multiple kinases, such as raf, VEGFR, PDGFR, FLT-3, and c-Kit.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BETA PHARMA CANADA INCMONTREAL QC H4P 2R2
ASTAR BIOTECH LLC800E LEIGH STREET SUITE 53 VIRGINIA BIOTECH CENTER RICHMOND VA 23219

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wang, Zhaoyin Kirkland, CA 73 1827
Yu, Chunrong Glen Allen, US 12 28

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 20, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00